Targeting NUPR1 for Cancer Treatment: A Risky Endeavor.

Targeting NUPR1 for Cancer Treatment: A Risky Endeavor.
Curr Cancer Drug Targets. 2020 Jul 03;:
Authors: Mansour SMA, Ali SA, Nofal S, Soror SH
Abstract
NUPR1 is a transcription factor that has attracted great attention because its various roles in cancer. Several studies were carried out to determine its molecular targets and mechanism of action to develop novel therapies against cancer. Here, we shed light on the role of NUPR1 in different types of cancer. NUPR1 regulates a complex network of pathways that may be affected by its silencing, which can cause varying effects. Its role in some types of cancer has been reported but remains incompletely understood whereas its roles in other types of cancers have not been reported yet. Therefore, targeting NUPR1 for cancer treatment remains challenging and risky.
PMID: 32619170 [PubMed - as supplied by publisher]

Source: Current Cancer Drug Targets - July 2, 2020 Category: Cancer & Oncology Authors: Mansour SMA, Ali SA, Nofal S, Soror SH Tags: Curr Cancer Drug Targets Source Type: research